vs
COUSINS PROPERTIES INC（CUZ）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
COUSINS PROPERTIES INC的季度营收约是Ultragenyx Pharmaceutical Inc.的1.2倍（$255.0M vs $207.3M），COUSINS PROPERTIES INC净利率更高（-1.4% vs -62.0%，领先60.7%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 13.2%），COUSINS PROPERTIES INC自由现金流更多（$135.0M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 10.4%）
Cousins Properties是一家公开上市的房地产投资信托（REIT），专注于亚特兰大、夏洛特、奥斯汀、菲尼克斯、坦帕及北卡罗来纳州教堂山的写字楼资产投资。公司曾开发多个知名地标项目，包括亚特兰大的CNN中心、奥姆尼体育馆、桃树中心191号大厦以及埃默里角商业综合体。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
CUZ vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $255.0M | $207.3M |
| 净利润 | $-3.5M | $-128.6M |
| 毛利率 | 67.4% | — |
| 营业利润率 | 67.5% | -54.7% |
| 净利率 | -1.4% | -62.0% |
| 营收同比 | 13.2% | 25.9% |
| 净利润同比 | -125.4% | 3.5% |
| 每股收益（稀释后） | $-0.02 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $255.0M | $207.3M | ||
| Q3 25 | $248.3M | $159.9M | ||
| Q2 25 | $240.1M | $166.5M | ||
| Q1 25 | $250.3M | $139.3M | ||
| Q4 24 | $225.3M | $164.6M | ||
| Q3 24 | $209.2M | $139.5M | ||
| Q2 24 | $213.0M | $147.0M | ||
| Q1 24 | $209.2M | $108.8M |
| Q4 25 | $-3.5M | $-128.6M | ||
| Q3 25 | $8.6M | $-180.4M | ||
| Q2 25 | $14.5M | $-115.0M | ||
| Q1 25 | $20.9M | $-151.1M | ||
| Q4 24 | $13.6M | $-133.2M | ||
| Q3 24 | $11.2M | $-133.5M | ||
| Q2 24 | $7.8M | $-131.6M | ||
| Q1 24 | $13.3M | $-170.7M |
| Q4 25 | 67.4% | — | ||
| Q3 25 | 67.8% | — | ||
| Q2 25 | 69.1% | — | ||
| Q1 25 | 69.2% | — | ||
| Q4 24 | 67.6% | — | ||
| Q3 24 | 68.5% | — | ||
| Q2 24 | 66.8% | — | ||
| Q1 24 | 66.0% | — |
| Q4 25 | 67.5% | -54.7% | ||
| Q3 25 | 68.1% | -106.9% | ||
| Q2 25 | 69.4% | -64.8% | ||
| Q1 25 | 66.0% | -102.6% | ||
| Q4 24 | 65.8% | -74.3% | ||
| Q3 24 | 67.9% | -94.6% | ||
| Q2 24 | 66.4% | -79.1% | ||
| Q1 24 | 66.3% | -151.9% |
| Q4 25 | -1.4% | -62.0% | ||
| Q3 25 | 3.5% | -112.8% | ||
| Q2 25 | 6.0% | -69.0% | ||
| Q1 25 | 8.3% | -108.5% | ||
| Q4 24 | 6.1% | -80.9% | ||
| Q3 24 | 5.4% | -95.7% | ||
| Q2 24 | 3.7% | -89.5% | ||
| Q1 24 | 6.4% | -156.8% |
| Q4 25 | $-0.02 | $-1.28 | ||
| Q3 25 | $0.05 | $-1.81 | ||
| Q2 25 | $0.09 | $-1.17 | ||
| Q1 25 | $0.12 | $-1.57 | ||
| Q4 24 | $0.09 | $-1.34 | ||
| Q3 24 | $0.07 | $-1.40 | ||
| Q2 24 | $0.05 | $-1.52 | ||
| Q1 24 | $0.09 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.7M | $421.0M |
| 总债务越低越好 | $3.3B | — |
| 股东权益账面价值 | $4.7B | $-80.0M |
| 总资产 | $8.9B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.71× | — |
8季度趋势，按日历期对齐
| Q4 25 | $5.7M | $421.0M | ||
| Q3 25 | $4.7M | $202.5M | ||
| Q2 25 | $416.8M | $176.3M | ||
| Q1 25 | $5.3M | $127.1M | ||
| Q4 24 | $7.3M | $174.0M | ||
| Q3 24 | $76.1M | $150.6M | ||
| Q2 24 | $6.0M | $480.7M | ||
| Q1 24 | $5.5M | $112.3M |
| Q4 25 | $3.3B | — | ||
| Q3 25 | $3.3B | — | ||
| Q2 25 | $3.5B | — | ||
| Q1 25 | $3.0B | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $2.7B | — | ||
| Q2 24 | $2.6B | — | ||
| Q1 24 | $2.6B | — |
| Q4 25 | $4.7B | $-80.0M | ||
| Q3 25 | $4.7B | $9.2M | ||
| Q2 25 | $4.8B | $151.3M | ||
| Q1 25 | $4.8B | $144.2M | ||
| Q4 24 | $4.8B | $255.0M | ||
| Q3 24 | $4.4B | $346.8M | ||
| Q2 24 | $4.5B | $432.4M | ||
| Q1 24 | $4.5B | $140.3M |
| Q4 25 | $8.9B | $1.5B | ||
| Q3 25 | $8.9B | $1.2B | ||
| Q2 25 | $9.1B | $1.3B | ||
| Q1 25 | $8.7B | $1.3B | ||
| Q4 24 | $8.8B | $1.5B | ||
| Q3 24 | $7.8B | $1.5B | ||
| Q2 24 | $7.7B | $1.6B | ||
| Q1 24 | $7.7B | $1.3B |
| Q4 25 | 0.71× | — | ||
| Q3 25 | 0.70× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.63× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.60× | — | ||
| Q2 24 | 0.58× | — | ||
| Q1 24 | 0.57× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $402.3M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $135.0M | $-100.8M |
| 自由现金流率自由现金流/营收 | 53.0% | -48.6% |
| 资本支出强度资本支出/营收 | 104.8% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $402.3M | $-99.8M | ||
| Q3 25 | $120.5M | $-91.4M | ||
| Q2 25 | $122.6M | $-108.3M | ||
| Q1 25 | $44.8M | $-166.5M | ||
| Q4 24 | $400.2M | $-79.3M | ||
| Q3 24 | $117.4M | $-67.0M | ||
| Q2 24 | $125.5M | $-77.0M | ||
| Q1 24 | $28.3M | $-190.7M |
| Q4 25 | $135.0M | $-100.8M | ||
| Q3 25 | — | $-92.7M | ||
| Q2 25 | — | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | $147.5M | $-79.5M | ||
| Q3 24 | — | $-68.6M | ||
| Q2 24 | — | $-79.0M | ||
| Q1 24 | — | $-193.9M |
| Q4 25 | 53.0% | -48.6% | ||
| Q3 25 | — | -58.0% | ||
| Q2 25 | — | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | 65.5% | -48.3% | ||
| Q3 24 | — | -49.2% | ||
| Q2 24 | — | -53.7% | ||
| Q1 24 | — | -178.2% |
| Q4 25 | 104.8% | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | 112.2% | 0.1% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | 14.03× | — | ||
| Q2 25 | 8.46× | — | ||
| Q1 25 | 2.14× | — | ||
| Q4 24 | 29.35× | — | ||
| Q3 24 | 10.48× | — | ||
| Q2 24 | 16.01× | — | ||
| Q1 24 | 2.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CUZ
| Rental Properties | $253.3M | 99% |
| Fee And Other Revenue | $1.7M | 1% |
| Other | $1.2M | 0% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
